Argenica Therapeutics

Argenica Therapeutics is developing therapeutics intended to reduce brain tissue death after stroke, other brain injuries and neurodegenerative diseases.

Pharmaceutical Manufacturing

Explore the company ↓Explore its lists ↓

Headquarters: Nedlands, AustraliaSource: RevenueBaseRetrieved October 13, 2026
Employee range: 1 to 10Source: RevenueBaseRetrieved October 13, 2026
Founded: 2019Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 4 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Argenica Therapeutics do?

The company intends to explore development and commercialisation of cationic arginine-rich peptides for additional neural injury conditions, including perinatal hypoxia, traumatic brain injury and spinal cord injury.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#9OF 14

Australia

Neuroscience drug developers

Snapshot: September 19, 2026

↗

#9OF 16

Australia

Neurostimulation companies

Snapshot: September 19, 2026

↗

#10OF 21

Australia

Neurotechnology companies

Snapshot: September 14, 2026

↗

#11OF 23

Australia

Neurotech companies

Snapshot: September 14, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Argenica Therapeutics

#9 Neuroscience drug developers

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/neuroscience-drug-developers/australia" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/argenica/recognition-companies-neuroscience-drug-developers-australia-20260920-c11834c07ea0175879477215dc24ee3723ebc69218cdfac3f703117ccea3455a.svg" alt="Argenica Therapeutics listed #9 on Neuroscience drug developers, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026 and September 19, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →